(Reuters) -Belgium-based Titan America is seeking a valuation of up to $3.32 billion in its New York listing, as the initial ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Dr Agarwal’s Healthcare IPO opens for subscription on January 29, offering a range of eye care services. The firm holds ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...

You can't currently use an exchange-traded fund (ETF) to gain passive exposure to DeepSeek because it's not a publicly traded ...

Higher valuations and subsiding volatility are laying the groundwork for a significant increase in initial public offerings ...

Malpani Pipes And Fittings Ltd on Tuesday said it has fixed the price band of Rs 85-90 per share for Rs 26 crore initial ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Titan America, which makes heavy building materials and operates primarily on the U.S. Eastern Seaboard, on Tuesday said it plans to sell 9 million shares at between $15 and $18 apiece in the IPO, for ...

Venture Global, a producer of liquified natural gas, made its stock market debut on Friday as President Trump plans to boost ...

Other banks may join to work on a share sale that could help the SoftBank Group Corp.-backed company raise about $1 billion, ...

Titan America is seeking a valuation of up to $3.32 billion in its New York initial public offering, the Belgium-based cement ...